Schroder Investment Management Group Sorrento Therapeutics, Inc. Transaction History

Schroder Investment Management Group

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.0 - $4.9 $746,764 - $1.83 Million	-373,382 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $1.59 Million - $2.47 Million	-341,439 Reduced 47.77%	373,382 $1.74 Million
Q3 2021 Nov 12, 2021	SELL	$7.41 - $10.99 $1.06 Million - $1.57 Million	-142,476 Reduced 16.62%	714,821 $5.45 Million
Q2 2021 Aug 13, 2021	BUY	$6.35 - $10.0 $2.71 Million - $4.26 Million	426,059 Added 98.8%	857,297 $8.31 Million
Q1 2021 May 17, 2021	BUY	$7.03 - $16.51 $3.03 Million - $7.12 Million	431,238 New	431,238 $3.57 Million

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.